Abstract

BackgroundChikungunya virus (CHIKV) is a mosquito-borne, arthrogenic Alphavirus that causes large epidemics in Africa, South-East Asia and India. Recently, CHIKV has been transmitted to humans in Southern Europe by invading and now established Asian tiger mosquitoes. To study the processing of envelope proteins E1 and E2 and to develop a CHIKV subunit vaccine, C-terminally his-tagged E1 and E2 envelope glycoproteins were produced at high levels in insect cells with baculovirus vectors using their native signal peptides located in CHIKV 6K and E3, respectively.ResultsExpression in the presence of either tunicamycin or furin inhibitor showed that a substantial portion of recombinant intracellular E1 and precursor E3E2 was glycosylated, but that a smaller fraction of E3E2 was processed by furin into mature E3 and E2. Deletion of the C-terminal transmembrane domains of E1 and E2 enabled secretion of furin-cleaved, fully processed E1 and E2 subunits, which could then be efficiently purified from cell culture fluid via metal affinity chromatography. Confocal laser scanning microscopy on living baculovirus-infected Sf21 cells revealed that full-length E1 and E2 translocated to the plasma membrane, suggesting similar posttranslational processing of E1 and E2, as in a natural CHIKV infection. Baculovirus-directed expression of E1 displayed fusogenic activity as concluded from syncytia formation. CHIKV-E2 was able to induce neutralizing antibodies in rabbits.ConclusionsChikungunya virus glycoproteins could be functionally expressed at high levels in insect cells and are properly glycosylated and cleaved by furin. The ability of purified, secreted CHIKV-E2 to induce neutralizing antibodies in rabbits underscores the potential use of E2 in a subunit vaccine to prevent CHIKV infections.

Highlights

  • Chikungunya virus (CHIKV) is a mosquito-borne, arthrogenic Alphavirus that causes large epidemics in Africa, South-East Asia and India

  • Spodoptera frugiperda 21 (Sf21) insect cells were infected with the respective recombinant baculoviruses at a multiplicity of infection (MOI) of 10 tissue culture infectious dose 50 (TCID50) units per cell and cells were harvested 72 h post infection, which appeared to be the optimal time point for harvesting

  • CHIKV 6KE1 was not detected by western analysis using a-His mabs, but was recognized well by a-E1 polyclonal antiserum

Read more

Summary

Introduction

Chikungunya virus (CHIKV) is a mosquito-borne, arthrogenic Alphavirus that causes large epidemics in Africa, South-East Asia and India. Chikungunya virus (CHIKV) is an arthropod-borne (arbo)virus that causes epidemics in Africa, India and South-East Asia [1]. Recent outbreaks in Italy in 2007 [2] and autochthonous transmission events in France in 2010 [3] exemplify the threat of continued spread of CHIKV in the Western world, which correlates with the concurrent expanding distribution of its insect vector. Islands in 2005/2006 was Ae. albopictus [4] This vector switch made the virus endemic in more temperate regions and resulted in the first European cases (Italy, 2007) of transmission by local populations of Ae. albopictus [1,5].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call